ANI Pharmaceuticals, Inc. ( ANIP) - Stock Earnings
ANIP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 24.1 million USD | 227.8 million USD |
| 2025Q4 | 27.5 million USD | 247.1 million USD |
| 2026Q1 | 29.5 million USD | 237.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ANIP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 18.8 million USD | 486.8 million USD |
| 2024 | -18.5 million USD | 614.4 million USD |
| 2025 | 78.3 million USD | 883.4 million USD |
| 2026 Est. | — | — |
ANIP
Price: $79.20
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.91 USD
P/E Ratio: 20.35
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 67658
Ebitda: 16.4 millionMarket Capitalization: 1.8 billion